The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory
Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina
More than 2,500 submissions are currently under review in the Food and Drug Administration's (FDA) cell and gene therapy pipeline
Expertise in exosomes isolation and characterization will drive innovation in this field
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years
The company has already embarked upon significant expansion in Turkey
Subscribe To Our Newsletter & Stay Updated
